Cannabinoid modulation of rat pup ultrasonic vocalizations

The present study investigated the effects of the cannabinoid receptor agonist CP 55,940 ((−)- cis-3-[2-hydroxy-4-(1,1-dimethylheptyl)phenyl]- trans-4-(3-hydroxypropyl)cyclohexanol) and the cannabinoid receptor antagonist SR 141716A ( N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-me...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	European journal of pharmacology 1996-10, Vol.313 (1), p.43-49
Hauptverfasser:	McGregor, Iain S., Dastur, Farhad N., McLellan, R.Ashley, Brown, Richard E.
Format:	Artikel
Sprache:	eng
Schlagworte:	Analysis of Variance Animals Animals, Newborn Anxiety Behavior, Animal - drug effects Benzazepines - pharmacology Biological and medical sciences Body Temperature - drug effects Cannabinoid Cannabinoids - antagonists & inhibitors Cannabinoids - pharmacology Cannabis CP 55,940 Cyclohexanols - antagonists & inhibitors Cyclohexanols - pharmacology Dopamine Antagonists - pharmacology Dose-Response Relationship, Drug Drug addictions Flumazenil - pharmacology GABA Modulators - pharmacology Hypothermia - chemically induced Medical sciences Motor Activity - drug effects Naloxone - pharmacology Narcotic Antagonists - pharmacology Piperidines - pharmacology Pyrazoles - pharmacology Rats Rimonabant SR 141716A Toxicology Ultrasonic vocalization Vocalization, Animal - drug effects
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!